than those used in recent single-cell transcriptome studies 16, 17 , therefore allowing correspondingly higher throughout. Within the droplets cells are lysed (Suppl. Fig. 1 ), target mRNA is reverse transcribed with target-specific primers and a two-step DNA barcoding process attaches both molecule-specific 20, 21 and droplet-specific barcodes to the cDNAs. After subsequent recovery and next generation sequencing, the dual barcoding strategy allows clustering of sequence reads into both their molecules and cells of origin. This allows extensive correction of errors and amplification biases 21 , clone counting at both the mRNA and cellular levels, heavy chain isotype determination, and importantly, recovery of full-length, natively paired V(D)J sequences of BCR and TCRs simultaneously at extremely high throughput.
Large scale recovery of B-cell VHVL pairs from a healthy blood sample
We initially developed the technology and assessed pairing capability and throughput with 3 million B-cells isolated by negative bead enrichment from peripheral blood of a healthy volunteer. The emulsion was split across six separate fractions which were 5 processed in parallel and not remixed prior to sequencing. We loaded the emulsion at 0.2 cells per droplet, giving a Poisson expectation that ~90% of occupied droplets contain single cells, which was consistent with emulsion droplet observations (Fig. 2a , Suppl. Fig. 2 ). After emulsion breaking and additional library processing steps we performed paired-end 325+300bp sequencing with Illumina MiSeq. To process the sequencing data, we used the droplet and molecular barcodes together to collect PCR replicate reads from each original mRNA molecule, and determined a consensus for each mRNA keeping only mRNA sequences built from at least two reads. We stitched forward and reverse reads to generate full-length products comprising the 5' UTR, complete V(D)J sequence, and constant region sufficient for isotype determination.
We then annotated rearranged immunoglobulin heavy and light chain sequences with IMGT High-VQuest 22 and/or IgBLAST 23 .
The resulting dataset contained 324,988 droplet barcodes that were associated with at least one heavy chain (VH) and one light chain (VL) mRNA, with 229,869 distinct VH clonal lineages present as estimated by heavy chain clustering analysis. Since this raw set includes data from multi-cell as well as single-cell droplets, we next enriched for data from single-cell droplets by filtering out droplet barcodes linked to nonunanimous heavy or light chain V(D)J sequences ( Figure 2b ). This step is made possible by the high diversity of typical immune repertoires, in which VH or VL mRNAs from two random cells will almost never match. and observation of the clone across emulsion fractions. Clones seen in multiple droplet barcodes could reflect clonal expansion or multi-barcode droplets, which are expected in ~37% of droplets given the initial λ = 1 Poisson dispersal of barcodes into droplets. However, any clone represented by > 8 droplet barcodes is likely to be genuinely expanded (Poisson probability in a single droplet < 10 -6 ). While overall only 6.0% of clones were seen in more than one emulsion fraction, for the clones seen in more than 8 droplet barcodes (0.7% overall), 99% of them were seen in more than one fraction. The 100 most frequent clones (30-137 droplet barcodes each, Fig 2d) were all seen in at least five of six fractions. We conclude that a combination of barcode counting and independent fraction analysis allows detection of rare expanded lineages amongst a vast background of non-expanded clones 24 . Notably however, even the most abundant expanded clone was present at less than one cell in a thousand, exemplifying the huge diversity of human peripheral immune repertoires.
We next compared the number of captured mRNAs of each VH and VL chain within pairs as an estimate of expression level (Fig. 2e) Recovery of known low frequency VHVL pairs from an HIV elite controller.
As a further validation of the pairing sensitivity and accuracy of our assay, we processed a sample where several rare (< 1 cell in 10,000) native VHVL pairings are already and publically known. We obtained peripheral B-cells from an HIV elite controller patient whose memory B cells have been mined heavily in recent years for antibodies displaying HIV neutralization activity 25, 26 . 350,000 B-cells were processed to generate a total of 38,620 filtered VHVL pairs. Interestingly, this individual showed a greater proportion of IgG than the previous healthy sample (Fig. 3a) or typical healthy peripheral B-cell repertoires 24, 27, 28 . We compared VH sequences from this dataset to all reported broadly neutralizing antibodies (bNAbs) from this individual including PGT121 29 and found eight close or identical VH sequences, indicating that this family of bNAbs represents less than 0.03% of circulating B-cells. Crucially, all light chains paired to these heavy chains were of the expected and similarly rare bNAb lineage, displaying the same Igλ-V3-21/J3 rearrangement and hallmark triple codon insertion as previously reported 26 , supporting the high accuracy and sensitivity of our method.
Furthermore, on a phylogenetic tree of all known and newly generated PGT121-like VHVL pairs from this individual (Fig. 3b) (Fig. 3c) . The antibodies expressed well and all showed strong neutralizing activity against the virus, demonstrating the utility of our approach in rapidly generating natively paired functional antibody variants from a relevant biological sample.
B-cell and T-cell receptor pairs from tumor infiltrating lymphocytes
Having validated our emulsion barcoding for high throughput recovery of paired receptors, we moved forwards with our primary objective of recovering immune receptors directly from a tumor. We took a protease-dissociated resected ovarian adenocarcinoma sample and entered 400,000 unsorted cells into emulsion. CD3/CD19
staining of a separate aliquot of the sample suggested substantial numbers of infiltrating B (~5%) and T cells (~20%) among the material. Single cell dispersal in the emulsion was similar to purified cells albeit with some limited clumping visible, and extensive variation in cell size and shape within the droplets as expected given the cell type heterogeneity of the sample ( total BCR pairs we observed 1,518 distinct heavy chain clones, with 15 clones at >1% frequency but none >5%. While this represents substantially more restricted diversity than the healthy peripheral BCR repertoire (where no clone was present in greater than 0.06% frequency), the presence of so many class-switched, mutated and highly expressed clones in the tumor sample demonstrates the necessity of a deep and sensitive sampling approach for TIL characterization. We conclude that our method allows rapid retrieval of large numbers of TIL immune receptor pairs, from both B and T cells simultaneously, without the need for prior sorting or exogenous activation of defined TIL populations. with CD8 mRNA, while only 0.6% were linked to CD4 mRNA (suppl. Fig 3) . This demonstrates the high specificity but limited sensitivity of an mRNA-based approach to cell phenotyping, similar to a previous report 31 . In contrast, proteins such as cell surface receptors are usually present in far higher numbers (1,000-100,000 per cell) than their coding mRNAs, potentially making them easier to detect as well as being potentially more directly relevant to cell phenotype. To measure target protein levels on each cell we conjugated custom oligonucleotide DNA labels to anti-human CD4
Capture of additional phenotypic markers of interest
and CD8 antibodies, and incubated the labeled antibodies with an unseparated mixture of CD4 + and CD8 + T-cells before entry of 30,000 cells into an emulsion (Fig. 5a ).
The DNA labels carry antibody-specific sequence tags as well as molecular barcodes and sequence complementarity to the amplified droplet barcodes, allowing emulsion droplet barcoding and molecular counting similarly to that done for mRNAs. We targeted the DNA labels as well as TCR, CD4 and CD8 mRNAs simultaneously. After sequencing and filtering we identified 3,682 droplet barcodes with high confidence TCR VαVβ pairs. Consistent with the previous experiment, roughly half (52%) of the TCR pairs could be assigned CD4 or CD8 status based on mRNA (Figure 5b) Application of this approach to TILs with an expanded, immune-oncology relevant marker set such as anti-PD-1 and anti-CTLA-4 is now warranted.
Discussion
In this study we processed several million unstimulated naïve and resting memory B- 
Methods

Cell preparation
For the study of 3 million healthy B-cells, 50 Table 1) , with template-switch-based addition of a universal adaptor sequence containing a randomized molecular barcode as previously described 21, 51 .
Following RT, emulsions were subjected to 40 cycles of thermocycling (each cycle: 82C for 10 sec, 65C for 25 sec) to perform PCR amplification of the droplet barcode templates, which were diluted in the initial lysis and reaction mix to 30,000 cp/μl, generating a concentration in the final mixture of 15,000 cp/ul or ~1 per ~65pl droplet. One end of the droplet barcode comprises the Illumina read 2 ("P7") primer site, whereas the other end matches the common sequence of the universal adaptor oligonucleotide. Therefore, during PCR, template-switched cDNAs can anneal to amplified droplet barcode strands and become spliced by overlap extension to produce full-length products containing target, molecular barcode and droplet barcode sequences.
Emulsion breaking, cleanup, downstream PCRs, pooling and sequencing
After thermocycling, the overlay solution was removed by pipetting and 40ul emulsion breaking solution (1:1 FC-40:perfluorooctanol) were added together with 15ul lysate clearing solution (12.5 μL Qiagen Protease, 2.5 μL 0.5 M Na-EDTA, pH 8.0). After inverting 10 times to break the emulsion, the mixture was incubated for 15 minutes at 50 °C and 3 minutes at 95 °C to inactivate the protease. After centrifugation at 15,000 × g for 1 min to isolate the aqueous phase, the recovered material was rigorously purified to remove oligonucleotides, reagents and excess droplet barcode PCR products. Since full length products contain biotin due to 5′ biotinylation of the RT primer, they can be efficiently separated from excess droplet barcode PCR products by cleanup on streptavidin beads, thus minimizing downstream PCR recombination artifacts, a common problem in extension-by-overlap approaches 52 . First products were purified using AMPure XP beads (Agencourt) using manufacturer's instructions at a 1:1 ratio, followed by cleanup using streptavidin beads (New England Biolabs) also using manufacturer's instructions, followed by elution in deionized water at 95 °C 53 , followed by a second cleanup with AMPure XP beads at a 1:1 ratio. Products were then entered into a target enrichment PCR in which primers specific to the constant regions of the B-or T-cell receptor targets (Supplementary Table 1) were used together with a primer specific to the universal end of the droplet barcode sequence. This reverse primer also contained a six-base index barcode for multiplexed sequencing on the MiSeq instrument according the manufacturer's 25 instructions. Thus, only full-length, droplet-barcoded target sequences are amplified in this step. We first amplified all targets together for seven cycles of 98C 10 seconds; 64C 20 seconds; 72C 15 seconds, using Q5 Hot Start polymerase (New England Biolabs) under manufacturerrecommended conditions, including a 2 minute 98C polymerase activation step at the beginning of the reaction. This was followed by AMPure XP cleanup at a 1.5:1 beads:PCR ratio.
We then performed a second seven-cycle targeting each chain (VH, VL, VA, VB) separately, using the same thermocycling conditions as before, followed by AMPure XP cleanup. We then performed a final PCR with the same thermocycling conditions and 5-15 cycles (depending on yield as judged by qPCR) to add the full-length Illumina sequencing adaptors and generate enough material for TapeStation D1000 (Agilent) quantification. We then pooled libraries and sequenced on the V3 2 x 300bp MiSeq platform (Illumina).
Modifications to the standard MiSeq platform
Reconstruction of the complete variable V(D)J region of BCR or TCR requires stitching the two paired-end Illumina reads. To improve this process we extended the forward read of the 2 x 300bp kit to 325bp. We used 10% phiX spike-in to alleviate issues of limited library diversity, since immune receptor libraries have limited diversity in the constant region primer sites.
Overview of bioinformatic processing of reads
Illumina MiSeq reads were processed using custom pipelines built around the pRESTO 
HIV bNAb candidate sequence discovery
New natively paired broadly-neutralizing antibodies (BNAbs) to HIV were discovered by mining our 38,620 VHVL pairs for similarity to known bNAb HCDR3s, VDJ sequences and Donor 27 manual inspection of phylogenetic trees of full V(D)J amino acid sequence to select antibody candidates interspersing with known bNAb sequences.
HIV bNAb protein expression and purification
Antibody sequences were synthesized and cloned into previously described heavy and light chain vectors 62, 63 . Heavy and light chain plasmids were co-transfected (1:1 ratio) in 293
FreeStyle cells using 293fectin (Invitrogen) according to the manufacturer's protocol. Antibody supernatants were harvested four days following transfection and purified by protein A affinity chromatography. Purified antibodies were buffer exchanged into PBS before use in further assays.
Pseudovirus production and neutralization assays
Pseudoviruses were generated by transfection of 293T cells with an HIV-1 Env expressing plasmid and an Env-deficient genomic backbone plasmid (pSG3ΔEnv), as described previously 64 . Pseudoviruses were harvested 72 hr post-transfection for use in neutralization assays. Neutralizing activity was assessed using a single round of replication pseudovirus assay and TZM-Bl target cells, as described previously 64 . Briefly, TZM-bl cells were seeded in a 96-well flat bottom plate. To this plate was added pseudovirus, which was preincubated with serial dilutions of antibody for 1 hr at 37 °C. Luciferase reporter gene expression was quantified 72 hr after infection upon lysis and addition of Bright-Glo Luciferase substrate (Promega). To determine IC50 values, dose-response curves were fit by nonlinear regression.
Ovarian tumor target chain identification
After simultaneous BCR and TCR capture from ovarian dissociated tumor tissue in emulsion, we filtered reads using molecular and droplet barcodes as previously described, but then After emulsion barcoding and sequencing, data was enriched for data from single-cell droplets and VHVL pairing precision was estimated using pair consistency among expanded clones. c) Heavy chain isotype (most abundant isotype within each droplet) and light chain locus usage for 259,368 filtered VHVL pairs. d) Rank abundance of the 100 most frequent heavy chain clones in each of six independent emulsion fractions. 0.05% overall frequency is marked. e) VH vs VL expression within cells as estimated by number of captured mRNAs within each droplet barcode. 5,000 points are shown for each isotype. VH versus VL mutation within pairs and distribution within each isotype. 
